Font Size: a A A
Keyword [anti- EGFR]
Result: 21 - 40 | Page: 2 of 2
21. The Effect And Mechanism Of The Fusion Protein Anti-EGFR-iRGD On Radiation Sensitization In Gastric Cancer
22. Structural And Functional Characterazation Of A Recombinant Anti-EGFR Monoclonal Antibody
23. Mechanism Of Transferrin Receptor (TFRC) On Radiosensitivity Of Nasopharyngeal Carcinoma (NPC) And Efficacy Of Chemotherapy Combined With Anti-EGFR MAb On Metastatic NPC
24. Establishment Of Recombinant Protein EGFR-single Domain Antibody-iRGD And Evaluation Of Recombinant Protein Together With Anticancer Drugs In The Treatment Of Gastric Cancer
25. The Construction Of The Fusion Protein Anti-EGFR-iRGD Decorated Red Blood Cell Membrane Derived Nano-carrier And Its Role In The Targeted Therapy Of Gastric Cancer
26. Anti-EGFR-PEG-SPIO Nanomolecular Probe In MRgFUS Ablation Lung Adenocarcinoma Model Imaging, Sensitization And Efficacy Monitoring
27. The Cytotoxicity Of Anti-EGFR Chimeric Antigen Receptor T Cells For Glioma Cell Lines
28. The Efficacy Of Anti-EGFR Therapy In Patients With (K)RAS Wild-type Metastatic Colorectal Cancer
29. Study On The Pharmacological Activity Of Aconitum Soongaricum Stapf.and Hydrolysis Products In Xinjiang Province Based On The Cell Membrane Chromatography
30. Antitumor Activity Of Anti-EGFR Chimeric Antigen Receptor T Cells Against Glioblastoma In Vitro And In Vivo
31. In Vitro Killing Effect Of Anti-EGFR Monoclonal Antibody-modified Gold Nanoparticles On Bladder Cancer T24 Cells Under Near-infrared Irradiation
32. Molecular Imaging Application Of Radioiodinated Anti-egfr Human Fab On Egfr-overexpressing Tumor Xenografts
33. Gadolinium Conjugate Of Bispecific Fusion Protein Anti-EGFR-iRGD As A MRI Contrast Agents For Early Detection Of Gastric Cancer:in Vitro And In Vivo Studies
34. LIMK1 Nuclear Translocation Promotes Tumor Progression And Achieves The Susceptibility From Anti-EGFR Therapies In Hepatocellular Carcinoma
35. The Design Of Novel Anti-EGFR Antibody-drug Conjugates And Studies On Their Antitumor Effect
36. Efficacy And Safety Of Maintenance Therapy Contained With Anti-EGFR Monoclonal Antibody In RAS And BRAF Wild-type Metastatic Colorectal Cancer
37. Association Between The Primary Site Of Head And Neck Squamous Cell Carcinoma And The Efficiecy Of Anti-EGFR Therapy
38. Investigation On The Site-specific Integration Of Anti-EGFR At The NW_003626341.1 Site In CHO Cells
39. Roles And Mechanisms Of LncRNA MIR100HG In Regulation Of Anti-EGFR Resistance And Metastasis In Colorectal Cancer
40. A Systematic Review And Meta-analysis Of The Efficacy And Safety Of Anti-EGFR Antibody "Rechallenge" In Metastatic Colorectal Cancer
  <<First  <Prev  Next>  Last>>  Jump to